Hervé Avet-Loiseau

Prognostic significance of copy-number alterations in multiple myeloma.

Cheng Li, Kenneth C. Anderson, Catherine Charbonnel, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genetics of multiple myeloma: another heterogeneity level?

N. Munshi, H. Avet-Loiseau, J. Corre, 2015, Blood.

Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma

Giovanni Parmigiani, Daniel Auclair, Kenneth C. Anderson, 2018, Leukemia.

Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.

P. Chevallier, H. Avet-Loiseau, J. Harousseau, 2004, Haematologica.

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.

Christian Jacques, Nizar Bahlis, Michele Cavo, 2014, The New England journal of medicine.

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Hartmut Goldschmidt, Meral Beksaç, Mario Boccadoro, 2011, Blood.

14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.

Laurence Lodé, Richard Garand, R. Bataille, 2003, Seminars in oncology.

Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.

Laurence Lodé, Catherine Charbonnel, Wilfried Gouraud, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

Gordon Cook, Monika Engelhardt, Hermann Einsele, 2020, Leukemia.